MARKETS / NYSE / MMM

NYSE · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP

3M Co. MMM

19 fiscal years on record · USD · FY2025 reported · SEC filings only

Revenue

$24.9B

▲ 1.5% YoY

Net income

$3.2B

▼ 22.1% YoY

Free cash flow

$1.4B

▲ 118.8% YoY

In brief

What this company does

Its business segments bring together common or related 3M technologies, which supports the development of products and services and the sharing of business resources across the Company. 3M products are sold through numerous distribution channels, including directly to users and through e-commerce, wholesalers, retailers, jobbers, distributors, and dealers in many countries. On December 31, 2025, the Company employed approximately 60,500 people, with approximately 22,500 employed in the United States and 38,000 employed internationally. The Company owns, or holds licenses to use, numerous U.S. and foreign patents. 3M Company was incorporated in 1929 under the laws of the State of Delaware to continue operations begun in 1902.

Written from the business description in 3M COMPANY's annual report to the U.S. Securities and Exchange Commission, filed 3 February 2026. Every sentence was checked against that document before publication.

Growth

USD 24.9B

Revenue, FY2025 · full 19-year series below

Revenue $B Net income $B

FY2025 · Revenue 24.9 · Net income 3.2

Compound annual growth

Revenue

−1.6%

−5.0%

−1.9%

−0.4%

Net income

−17.4%

−9.8%

−3.9%

−1.5%

EPS, diluted

−16.2%

−8.5%

−2.3%

+0.4%

Dividend / share

−21.2%

−13.1%

−0.5%

+2.2%

Returned to shareholders

−0.1%

+5.1%

−4.7%

+4.9%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at −5.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

13 cents

of every revenue dollar became profit

Operating margin Net margin

FY2025 · Operating 18.6% · Net 13.1%

ROE

FY2025 · ROE 76.1%

Gross margin39.9%

Operating margin18.6%

Net margin13.1%

Return on assets8.4%

EBITDAUSD 5.9B

Each USD of equity produced 76 cents of profit this year.

Cash & shareholders

USD 4.8B

returned in FY2025 · dividends + net buybacks

Free cash flow $B

FY2025 · FCF 1.4

Net buybacks $B Dividends $B

FY2025 · Dividends 1.6 · Net buybacks 3.3

Dividends paidUSD 1.6B

Net buybacksUSD 3.3B

Share of profit148.1%

Consecutive raises—

USD 1.6B in dividends and USD 3.3B in buybacks — 148% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 37.7B

EquityUSD 4.7B

CashUSD 5.2B

Gross debtUSD 12.6B

Net debtUSD 7.4B

Current ratio1.71×

Net debt stands at 157% of equity.

The 19-year record

19 fiscal years

Every figure from documents filed with the SEC · USD

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue $B	24.9	24.6	24.6	26.2	35.4	32.2	32.1	32.8	31.7	30.1	30.3	31.8	30.9	29.9	29.6	26.7	23.1	25.3	24.5
Operating income $B	4.6	4.8	−10.7	4.4	7.4	7.2	6.2	7.2	7.7	7.0	6.9	7.1	6.7	6.5	6.2	5.9	4.8	5.2	6.2
EBITDA $B	5.9	6.2	−8.7	6.2	9.3	9.1	7.8	8.7	9.2	8.5	8.4	8.5	8.0	7.8	7.4	7.0	6.0	6.4	·
Income tax $B	1.0	0.8	−2.9	0.2	1.3	1.3	1.1	1.6	2.7	2.0	2.0	2.0	1.8	1.8	1.7	1.6	1.4	1.6	2.0
Net income $B	3.2	4.2	−7.0	5.8	5.9	5.4	4.5	5.3	4.9	5.0	4.8	5.0	4.7	4.4	4.3	4.1	3.2	3.5	4.1
Free cash flow $B	1.4	0.6	5.1	3.8	5.9	6.6	5.4	4.9	4.9	5.2	5.0	5.1	4.2	3.8	3.9	4.1	4.0	3.1	2.8
EPS, diluted $	6.00	7.55	−12.63	10.18	10.12	9.36	7.72	8.89	7.93	8.16	7.58	7.49	6.72	6.32	5.96	5.63	4.52	4.89	5.60
Dividend / sh $	2.92	3.61	6.00	5.96	5.92	5.88	5.76	5.44	4.70	4.44	3.08	3.59	3.40	2.36	2.20	2.10	2.04	2.00	1.92
Payout %	48	47	−47	58	58	62	73	60	58	53	53	45	37	37	36	37	45	40	34
ROE %	76.1	96.5	−71.6	38.8	42.4	47.5	45.5	50.1	44.4	46.5	39.4	32.4	26.6	26.9	27.6	28.7	28.2	35.0	·
Shares out B	0.53	0.54	0.55	0.55	0.57	0.58	0.58	0.58	0.59	0.60	0.61	0.64	0.66	0.69	0.69	0.71	0.71	0.69	·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Compare

This company against its peers

3M Co.vsThermo Fisher Scientific Inc.Same industry: Surgical & Medical Instruments & Apparatus 3M Co.vsNorthrop Grumman Corp.Same industry: Surgical & Medical Instruments & Apparatus 3M Co.vsMedtronic PLCSame industry: Surgical & Medical Instruments & Apparatus 3M Co.vsStryker Corp.Same industry: Surgical & Medical Instruments & Apparatus 3M Co.vsDanaher Corp.Same industry: Surgical & Medical Instruments & Apparatus 3M Co.vsBecton Dickinson & Co.Same industry: Surgical & Medical Instruments & Apparatus 3M Co.vsTrane Technologies PLCSame industry: Surgical & Medical Instruments & Apparatus

Provenance

Company facts, as filed

How we verify · 0 failures in 74 reconciliationsAUDITED

Reconciled in 19 of 19 fiscal years. 2 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivitySurgical & Medical Instruments & Apparatus

Listed onNYSE

Incorporated inDelaware

Fiscal year endsDecember 31

Data on record since2007